Winer KK - Search Results

1

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr. Winer KK, et al. J Clin Endocrinol Metab. 2003 Sep;88(9):4214-20. doi: 10.1210/jc.2002-021736. J Clin Endocrinol Metab. 2003. PMID: 12970289 Clinical Trial.

2

Chiari malformation type 1 and osteoporosis.

Koch CA, Heiss JD, Pacak K, Krakoff J, Winer KK, Wassermann EM. Koch CA, et al. Among authors: winer kk. Neurosurg Rev. 2000 Sep;23(3):171-2. doi: 10.1007/pl00011952. Neurosurg Rev. 2000. PMID: 11086745 No abstract available.

3

Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism.

Baron J, Winer KK, Yanovski JA, Cunningham AW, Laue L, Zimmerman D, Cutler GB Jr. Baron J, et al. Among authors: winer kk. Hum Mol Genet. 1996 May;5(5):601-6. doi: 10.1093/hmg/5.5.601. Hum Mol Genet. 1996. PMID: 8733126

4

Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

Winer KK, Yanovski JA, Cutler GB Jr. Winer KK, et al. JAMA. 1996 Aug 28;276(8):631-6. JAMA. 1996. PMID: 8773636 Clinical Trial.

5

Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptor.

De Luca F, Ray K, Mancilla EE, Fan GF, Winer KK, Gore P, Spiegel AM, Baron J. De Luca F, et al. Among authors: winer kk. J Clin Endocrinol Metab. 1997 Aug;82(8):2710-5. doi: 10.1210/jcem.82.8.4166. J Clin Endocrinol Metab. 1997. PMID: 9253358

6

A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.

Winer KK, Yanovski JA, Sarani B, Cutler GB Jr. Winer KK, et al. J Clin Endocrinol Metab. 1998 Oct;83(10):3480-6. doi: 10.1210/jcem.83.10.5185. J Clin Endocrinol Metab. 1998. PMID: 9768650 Clinical Trial.

7

FGF-23 is elevated by chronic hyperphosphatemia.

Gupta A, Winer K, Econs MJ, Marx SJ, Collins MT. Gupta A, et al. J Clin Endocrinol Metab. 2004 Sep;89(9):4489-92. doi: 10.1210/jc.2004-0724. J Clin Endocrinol Metab. 2004. PMID: 15356053

8

Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

Collins MT, Lindsay JR, Jain A, Kelly MH, Cutler CM, Weinstein LS, Liu J, Fedarko NS, Winer KK. Collins MT, et al. Among authors: winer kk. J Bone Miner Res. 2005 Nov;20(11):1944-50. doi: 10.1359/JBMR.050718. Epub 2005 Jul 18. J Bone Miner Res. 2005. PMID: 16234967 Free article.

9

Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.

Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr. Winer KK, et al. J Clin Endocrinol Metab. 2008 Sep;93(9):3389-95. doi: 10.1210/jc.2007-2552. Epub 2008 May 20. J Clin Endocrinol Metab. 2008. PMID: 18492754 Free PMC article. Clinical Trial.

10

PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.

Theman TA, Collins MT, Dempster DW, Zhou H, Reynolds JC, Brahim JS, Roschger P, Klaushofer K, Winer KK. Theman TA, et al. Among authors: winer kk. J Bone Miner Res. 2009 May;24(5):964-73. doi: 10.1359/jbmr.081233. J Bone Miner Res. 2009. PMID: 19063686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page